<?xml version="1.0" encoding="UTF-8"?>
<p id="Par39">The in vitro antimicrobial screening of the synthesized 1,2,4-triazole derivatives (
 <bold>T</bold>
 <sub>
  <bold>1</bold>
 </sub>–
 <bold>T</bold>
 <sub>
  <bold>20</bold>
 </sub>) in μM was determined against Gram-positive 
 <italic>Bacillus subtilis</italic>, 
 <italic>Pseudomonas aeruginosa</italic>, Gram-negative 
 <italic>Escherichia coli</italic> bacterium and fungal strains 
 <italic>Candida albicans</italic> and 
 <italic>Aspergillus niger</italic> by tube dilution method using ciprofloxacin, amoxycillin (antibacterial) and fluconazole (antifungal) as reference drugs. DMSO was used to dissolve the reference and sample derivatives (
 <bold>T</bold>
 <sub>
  <bold>1</bold>
 </sub>–
 <bold>T</bold>
 <sub>
  <bold>20</bold>
 </sub>). Dilutions were prepared in nutrient broth (I.P.) for bacterial (incubated at 37 ± 1 °C for 24 h) and Sabouraud dextrose broth (I.P.) for fungal species (37 ± 1 °C for 48 h for 
 <italic>C. albicans</italic>) and (25 ± 1 °C for 7 days for 
 <italic>A. niger</italic>) (Table 
 <xref rid="Tab3" ref-type="table">3</xref>, Figs. 
 <xref rid="Fig4" ref-type="fig">4</xref> and 
 <xref rid="Fig5" ref-type="fig">5</xref>) [
 <xref ref-type="bibr" rid="CR17">17</xref>].
</p>
